[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL415001A1 - Kompozycje farmaceutyczne zawierające kwas mykofenolowy lub sól mykofenolanową - Google Patents

Kompozycje farmaceutyczne zawierające kwas mykofenolowy lub sól mykofenolanową

Info

Publication number
PL415001A1
PL415001A1 PL415001A PL41500102A PL415001A1 PL 415001 A1 PL415001 A1 PL 415001A1 PL 415001 A PL415001 A PL 415001A PL 41500102 A PL41500102 A PL 41500102A PL 415001 A1 PL415001 A1 PL 415001A1
Authority
PL
Poland
Prior art keywords
pharmaceutical compositions
mycophenolic acid
compositions containing
containing mycophenolic
mycophenolate salt
Prior art date
Application number
PL415001A
Other languages
English (en)
Inventor
Jürgen Dederichs
Thomas Rigassi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL415001(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL415001A1 publication Critical patent/PL415001A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Przedmiotem wynalazku jest stała postać dawkowania np. tabletka zawierająca kwas mykofenolowy lub sól mykofenolową i proces jej wytwarzania.
PL415001A 2001-10-17 2002-10-16 Kompozycje farmaceutyczne zawierające kwas mykofenolowy lub sól mykofenolanową PL415001A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds

Publications (1)

Publication Number Publication Date
PL415001A1 true PL415001A1 (pl) 2016-02-29

Family

ID=9924043

Family Applications (2)

Application Number Title Priority Date Filing Date
PL415001A PL415001A1 (pl) 2001-10-17 2002-10-16 Kompozycje farmaceutyczne zawierające kwas mykofenolowy lub sól mykofenolanową
PL367738A PL234541B1 (pl) 2001-10-17 2002-10-16 Sposób wytwarzania tabletki dojelitowej zawierającej kwas mykofenolowy lub sól mykofenolanową

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL367738A PL234541B1 (pl) 2001-10-17 2002-10-16 Sposób wytwarzania tabletki dojelitowej zawierającej kwas mykofenolowy lub sól mykofenolanową

Country Status (32)

Country Link
US (3) US20050013859A1 (pl)
EP (1) EP1438040B2 (pl)
JP (2) JP2005508959A (pl)
KR (1) KR100671367B1 (pl)
CN (1) CN1310640C (pl)
AR (2) AR036813A1 (pl)
AT (1) ATE374023T1 (pl)
AU (1) AU2002338897B2 (pl)
BR (1) BR0213355A (pl)
CA (1) CA2460574A1 (pl)
CO (1) CO5390076A1 (pl)
CY (1) CY1107841T1 (pl)
DE (1) DE60222687T3 (pl)
DK (1) DK1438040T4 (pl)
EC (2) ECSP024342A (pl)
ES (1) ES2292819T5 (pl)
GB (1) GB0124953D0 (pl)
HK (1) HK1067861A1 (pl)
HU (1) HU231114B1 (pl)
IL (2) IL160968A0 (pl)
MX (1) MXPA04003636A (pl)
MY (1) MY139206A (pl)
NO (1) NO341804B1 (pl)
NZ (1) NZ532280A (pl)
PE (1) PE20030476A1 (pl)
PL (2) PL415001A1 (pl)
PT (1) PT1438040E (pl)
RU (2) RU2338528C2 (pl)
SI (1) SI1438040T2 (pl)
TW (1) TWI333861B (pl)
WO (1) WO2003032978A1 (pl)
ZA (1) ZA200401977B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
ATE461182T1 (de) * 2004-07-20 2010-04-15 Teva Gyogyszergyar Zartkoeruen Kristallines mycophenolat-natrium
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
WO2006086498A2 (en) 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
WO2006086500A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Compositions and methods for treating vascular, autoimmune and inflammatory diseases
CN101272780A (zh) * 2005-09-30 2008-09-24 诺瓦提斯公司 用于自身免疫疾病和移植排斥治疗的dpp iv抑制剂
EP1965760B1 (de) 2005-12-21 2013-02-27 Basf Se Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel
RU2008136574A (ru) * 2006-02-13 2010-03-27 Новартис АГ (CH) Высокая дозировка микофеноловой кислоты (мфк)
EP2164460B1 (de) 2007-06-06 2017-08-09 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
CA2686964A1 (en) 2007-06-06 2008-12-11 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
RU2010109408A (ru) * 2007-08-13 2011-09-20 Панацея Биотек Лимитед (In) Композиции с пролонгированным высвобождением, включающие микофенолят натрия, и их действия
US20110008426A1 (en) * 2008-03-05 2011-01-13 Rajesh Jain Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
CA2729834A1 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011046546A1 (en) * 2009-10-13 2011-04-21 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
AU2018236225B2 (en) * 2017-03-13 2023-11-30 Okava Pharmaceuticals, Inc. Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
MX2020013210A (es) 2018-06-06 2021-02-26 Metavant Sciences Gmbh Metodos de tratamiento de sujetos que padecen diabetes con enfermedad renal cronica.
KR20210003786A (ko) * 2018-06-14 2021-01-12 폭셀 당뇨병의 치료에서 사용하기 위한 트리아진 유도체를 포함하는 필름 코팅정
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
TW202245741A (zh) * 2021-01-28 2022-12-01 法商普萊歐塞拉公司 使用s1p受體調節劑之治療方法
US20240261218A1 (en) * 2021-05-26 2024-08-08 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
AU3178293A (en) * 1992-11-24 1994-06-22 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
DK0686034T3 (da) * 1993-02-26 2001-08-27 Procter & Gamble Bisacodyl-doseringsform
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
RU2150942C1 (ru) * 1993-10-01 2000-06-20 Синтекс (Ю.ЭС.ЭЙ.) Инк. Оральные суспензии, содержащие высокие дозы мофетила микофенолята
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
WO2000067773A2 (en) * 1999-05-10 2000-11-16 Novartis Ag Combinations of immunosupressive agents for the treatment or prevention of graft rejections
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
EP1259631B1 (en) * 2000-02-29 2005-10-12 Biocon Limited Manufacture and purification of mycophenolic acid
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
MY139206A (en) 2009-08-28
PL367738A1 (pl) 2005-03-07
CO5390076A1 (es) 2004-04-30
DK1438040T3 (da) 2008-02-04
AR036813A1 (es) 2004-10-06
PT1438040E (pt) 2008-01-02
WO2003032978A1 (en) 2003-04-24
EP1438040B2 (en) 2019-10-16
IL160968A0 (en) 2004-08-31
ES2292819T3 (es) 2008-03-16
HK1067861A1 (en) 2005-04-22
IL160968A (en) 2016-04-21
PL234541B1 (pl) 2020-03-31
SI1438040T1 (sl) 2008-04-30
CN1310640C (zh) 2007-04-18
ECSP024341A (es) 2003-12-01
EP1438040B1 (en) 2007-09-26
CY1107841T1 (el) 2013-06-19
JP2005508959A (ja) 2005-04-07
ECSP024342A (es) 2003-03-10
CA2460574A1 (en) 2003-04-24
RU2007130786A (ru) 2009-02-20
EP1438040A1 (en) 2004-07-21
DK1438040T4 (da) 2020-01-27
US20100210717A1 (en) 2010-08-19
GB0124953D0 (en) 2001-12-05
ES2292819T5 (es) 2020-05-29
PE20030476A1 (es) 2003-07-30
HUP0600451A2 (en) 2006-09-28
RU2381026C2 (ru) 2010-02-10
MXPA04003636A (es) 2004-07-27
DE60222687D1 (de) 2007-11-08
DE60222687T3 (de) 2020-03-05
DE60222687T2 (de) 2008-07-17
NZ532280A (en) 2007-05-31
AR085778A2 (es) 2013-10-30
ATE374023T1 (de) 2007-10-15
NO341804B1 (no) 2018-01-22
NO20041785L (no) 2004-05-03
KR100671367B1 (ko) 2007-01-19
BR0213355A (pt) 2006-05-23
CN1564684A (zh) 2005-01-12
ZA200401977B (en) 2006-05-31
US20120237601A1 (en) 2012-09-20
JP2009137996A (ja) 2009-06-25
KR20050037409A (ko) 2005-04-21
HU231114B1 (hu) 2020-09-28
RU2338528C2 (ru) 2008-11-20
TWI333861B (en) 2010-12-01
SI1438040T2 (sl) 2020-02-28
US20050013859A1 (en) 2005-01-20
RU2004115332A (ru) 2005-04-20
AU2002338897B2 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
PL415001A1 (pl) Kompozycje farmaceutyczne zawierające kwas mykofenolowy lub sól mykofenolanową
MX9203396A (es) Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
NO20034230L (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
SE0301010D0 (sv) Novel compounds
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
SE0101675D0 (sv) Novel composition
SE0301009D0 (sv) Novel compounds
UY27548A1 (es) Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
ATE468126T1 (de) Ingwer-extraktzubereitung
BR0313220A (pt) Pelìcula de revestimento para comprimidos e cápsulas
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
BR0316724A (pt) Compostos, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
DK0557389T3 (da) Fremgangsmåde til fremstilling af tabletter indeholdende cephalosporansyrederivater ved direkte komprimering
EA200700703A1 (ru) Гранулярные препараты габоксадола
ES2076838T3 (es) Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen.
EA200700203A1 (ru) Фармацевтическая композиция, содержащая габапентин
UY26971A1 (es) Nuevos antagonistas de neuroquinina, procedimiento para su preparación y composiciones farmacéuticas que contienen estos compuestos
EA200400954A1 (ru) Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту
BR9905904A (pt) Compostos espiro imidazolina, um processo para a sua preparação e composições farmacêuticas contendo os mesmos
DE602004025965D1 (en) Phosphinsäurederivate
IT1265045B1 (it) Composizione farmaceutica atta a inibire la sintesi della lipoproteina (a)
UY26522A1 (es) " derivados de aminometil-fenil- ciclohexano sustituidos, procedimiento para su preparación, su uso para la preparación de medicamentos y medicamentos que contienen estos compuestos".